DBD-CAP was shown to affect also the proteolytic potential of tumor cells since it significantly down-regulated the expression of MMP-1, MT1-MMP and uPA in the metastatic ER- breast cancer cells (Figures 10B–D). Here, MMP1 is linked to breast carcinoma.